| 1998 |
Proteolysis of eIF4GII (EIF4G3) by poliovirus-induced mechanisms is required for complete shutoff of host cell protein synthesis after poliovirus infection; cleavage of eIF4GI alone is insufficient, and full shutoff coincides with cleavage of both eIF4GI and eIF4GII. |
Western blot analysis of eIF4GII cleavage kinetics in poliovirus-infected HeLa cells, with and without virus replication inhibitors; correlation with host protein synthesis rates |
Proceedings of the National Academy of Sciences of the United States of America |
High |
9736694
|
| 1999 |
Cleavage of eIF4GII (EIF4G3) by human rhinovirus 14 (HRV-14) 2A protease is the rate-limiting step in the shutoff of host cell protein synthesis after rhinovirus infection, with eIF4GII cleavage lagging behind eIF4GI cleavage. |
Western blot analysis of eIF4GI and eIF4GII cleavage kinetics in HRV-14-infected HeLa cells correlated with metabolic labeling of protein synthesis |
Journal of virology |
High |
10074204
|
| 2001 |
eIF4GII (EIF4G3) directly interacts with the FMDV IRES; the C-terminal fragment of eIF4GII generated by Lb protease cleavage retains IRES-binding activity. The RNA determinants for eIF4GII–IRES interaction are shared with eIF4GI. |
UV crosslinking and competition assays; in vitro cleavage with FMDV Lb protease followed by IRES binding assays |
RNA (New York, N.Y.) |
Medium |
11565745
|
| 2002 |
eIF4GII (EIF4G3) is NOT a substrate for HIV-1 protease in vitro, in contrast to eIF4GI which is cleaved at multiple sites by HIV-1 protease. |
In vitro cleavage assay using cell extracts and rabbit reticulocyte lysate system with recombinant HIV-1 protease; western blot detection |
Journal of molecular biology |
Medium |
12054764
|
| 2002 |
Human rhinovirus 2 2A protease directly cleaves both eIF4GI and eIF4GII (not via activation of a cellular protease), as demonstrated using a thermosensitive 2A protease mutant. |
Temperature-shift experiments with thermosensitive HRV2 2A protease mutant in cytoplasmic HeLa cell extracts; western blot of cleavage products |
FEBS letters |
Medium |
12123803
|
| 2003 |
The cleavage site of human rhinovirus 2 2A protease in eIF4GII (EIF4G3) is PLLNV(699)*GSR, located seven amino acids C-terminal to the corresponding cleavage site in eIF4GI (LSTR681*GPP), demonstrating the two isoforms have distinct cleavage sites. |
In vitro cleavage assay with recombinant HRV2 2Apro; N-terminal sequencing of cleavage products |
Journal of virology |
High |
12663812
|
| 2004 |
eIF4GII (EIF4G3), but not eIF4GI, is selectively recruited to capped mRNA at the onset of cell differentiation (erythropoiesis/thrombopoiesis), coincident with strong and long-lasting eIF4E phosphorylation and release of 4E-BP1 from the cap structure. Cytokines such as thrombopoietin differentially regulate eIF4GI vs. eIF4GII activities. |
m7GTP-Sepharose cap-affinity pulldown from differentiating cells; western blot; phosphorylation analysis |
Molecular and cellular biology |
Medium |
15143184
|
| 2006 |
eIF4GII (EIF4G3) integrity is required for reinitiation of translation of pre-existing mRNAs after polysome run-off; de novo translation of newly synthesized mRNAs is more dependent on eIF4GI. Translation of Hsp70 mRNA is more susceptible to eIF4GII hydrolysis than to eIF4GI hydrolysis. |
Electroporation of IRES-driven poliovirus 2Apro mRNA in HeLa and BHK-21 cells causing differential cleavage of eIF4GI vs. eIF4GII; luciferase reporter assays; metabolic labeling |
The Journal of biological chemistry |
Medium |
16959778
|
| 2009 |
FRET-based biosensors confirmed that EV 2A protease directly and specifically cleaves eIF4GII (EIF4G3) in intact infected cells, independent of other viral proteases, activated caspases, or general translation inhibition. |
FRET biosensors with GFP2-cleavage motif-DsRed2 fusion constructs expressed in cells; quantitative fluorescence imaging during EV infection |
Biotechnology and bioengineering |
Medium |
19655339
|
| 2009 |
Depletion of eIF4GI or eIF4GII individually only moderately inhibits cellular protein synthesis, whereas depletion of both has a slightly higher effect. VSV mRNA translation does not require eIF4GI/II, while vaccinia virus mRNA translation is substantially reduced by eIF4G depletion. |
siRNA depletion of eIF4GI and/or eIF4GII in HeLa cells; metabolic labeling; western blot |
Journal of molecular biology |
Medium |
19769989
|
| 2010 |
EIF4G3 is required for translation of HSPA2 protein in mouse spermatocytes; loss-of-function (repro8 ENU mutation in Eif4g3) causes absence of HSPA2 protein despite presence of Hspa2 transcript, dramatically reduced CDK1 (CDC2A) kinase activity, and arrest at the G2/MI meiotic transition causing male infertility. |
ENU mutagenesis screen; genetic mapping; Sanger sequencing of Eif4g3 mutation; western blot for HSPA2 and CDK1 activity assay in mutant spermatocytes; RT-PCR confirming transcript presence |
Development (Cambridge, England) |
High |
20430745
|
| 2012 |
DEAF1 transcriptionally regulates Eif4g3 expression in lymph node stromal cells; reduced DEAF1 function decreases eIF4GII levels and results in diminished polysomal translation of multiple genes including Anpep (aminopeptidase N). |
Deaf1 knockout mice and siRNA silencing; qRT-PCR; polysome profiling; western blot |
Journal of molecular cell biology |
Medium |
22923498
|
| 2012 |
CaMKI phosphorylates eIF4GII (EIF4G3) at Ser1156 in response to neuronal activity, promoting selective recruitment of eIF4GII (but not eIF4GI) to the eIF4F cap-binding complex, thereby enhancing cap-dependent translation. This mechanism regulates dendritic spine formation without affecting dendritic arborization. |
In vitro CaMKI phosphorylation assays; m7GTP-Sepharose pulldown from neurons treated with bicuculline/gabazine; S1156A phosphomutant; CaMKK inhibitor STO-609; RNAi knockdown of CaMKI isoforms and eIF4GII; bicistronic luciferase reporter; confocal imaging of spine density |
The Journal of neuroscience : the official journal of the Society for Neuroscience |
High |
22514323
|
| 2012 |
Multiple isoforms of eIF4GII (EIF4G3) are generated via alternative promoters, alternative splicing, and a non-canonical CUG initiation codon that extends the N-terminus. Novel eIF4GII isoforms rescue translation in eIF4GI/eIF4GII double-knockdown cells as effectively as eIF4GIf/e isoforms, suggesting the eIF4GII N-terminus plays a distinct role in initiation factor assembly. |
5' RACE, RT-PCR, reporter assays, RNAi knockdown of eIF4GI and eIF4GII followed by rescue with isoform expression constructs; metabolic labeling |
The Biochemical journal |
Medium |
22909319
|
| 2013 |
eIF4GII (EIF4G3) undergoes novel Cdk1-dependent N-terminal phosphorylation in nocodazole-arrested cells. Translation initiation factors including eIF4GII are enriched at microtubule organizing centers, mitotic spindle, and midbody during cytokinesis. |
Confocal microscopy; phosphorylation analysis by mobility shift; synchronized HeLa cells using thymidine block or Cdk1 inhibitor RO3306; metabolic labeling |
Cell cycle (Georgetown, Tex.) |
Medium |
24091728
|
| 2014 |
miR-520c-3p directly targets eIF4GII (EIF4G3) mRNA to negatively regulate eIF4GII protein synthesis; downregulation of eIF4GII by siRNA decreases global translation, cell proliferation, and colony formation ability, and induces cellular senescence in HeLa and DLBCL cells. |
miRNA overexpression, western blot, siRNA knockdown of eIF4GII, colony formation assays, xenograft mouse model, luciferase reporter (implied by direct targeting claim) |
PLoS genetics |
Medium |
24497838
|
| 2018 |
EIF4G3 localizes to the nucleus of mouse spermatocytes and is highly enriched in the XY body (the transcriptionally inactive sex chromosome domain); many translation-related proteins also localize to the XY body, suggesting a role in mRNA metabolism or poising of translation complexes before meiotic divisions. |
Immunofluorescence confocal microscopy and fractionation during spermatogenesis; co-localization with XY body markers |
Biology of reproduction |
Medium |
29161344
|
| 2001 |
Both eIF4GI and eIF4GII are cleaved in Jurkat T cells treated with proteasome inhibitors (MG132, lactacystin) or immunosuppressants (FTY720, cyclosporin A) via caspase-8-independent mechanisms. Novel eIF4GI cleavage fragments generated lack the ability to interact with eIF4E. |
Western blot with specific anti-peptide antisera against eIF4GI and eIF4GII in wild-type and caspase-8-deficient Jurkat cells; caspase activity assays |
FEBS letters |
Medium |
11513883
|